AIN

Business Context and Reporting Period

Company: Albany International Corp.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2006
Business Overview: The Company operates in three segments: Paper Machine Clothing (PMC), Applied Technologies, and Albany Door Systems. PMC is the primary segment, accounting for approximately 73% of consolidated net sales in 2006. The Company designs, manufactures, and markets fabrics and belts for paper machines, advanced textiles for various industries (aerospace, filtration, insulation), and high-performance industrial doors.

Key Financial Metrics (2006)

Material Changes vs. Prior Period

• Revenue Growth: Consolidated net sales increased 3.3% to $1.01 billion. Excluding currency translation and a $7.6 million reduction due to a change in contract terms with a major customer, organic sales grew 3.2%.
• Profitability Decline: Operating income decreased 22% to $90.3 million. This was driven by a lower gross profit margin (down 140 basis points) and higher Selling, General, and Technical expenses. The PMC segment faced price competition in Europe, leading to lower sales volume in Q3 and Q4.
• Segment Performance:
  • PMC: Sales increased slightly (0.6%) but operating income dropped significantly ($138.9M vs $165.0M) due to European pricing pressures and higher material costs.
  • Applied Technologies: Sales grew 15.8% (14.8% organic), but operating income declined ($17.4M vs $20.5M) due to ramp-up costs for manufacturing and engineering.
  • Albany Door Systems: Sales grew 7.0% and operating income increased to $8.1 million.
• Debt Structure: Long-term debt increased significantly due to the issuance of $180 million in 2.25% convertible notes in March 2006 and a $150 million private placement in October 2005. The Company terminated its accounts receivable securitization program in September 2006, impacting cash flow.
• Accounting Changes: Adoption of FAS No. 158 resulted in a $59.6 million increase in pension liabilities and a $41.5 million decrease in shareholders' equity. Adoption of SAB 108 resulted in a $2.1 million expense adjustment.

Guidance, Outlook, and Risks

• Outlook: Management expresses "cautious optimism" for a gradual recovery in revenue and operating income in 2007. They expect to offset the negative impact of European PMC pricing by the end of 2007. Orders in all three segments are strong.
• Capital Spending: 2007 capital spending is expected to range from $160 million to $180 million, primarily for PMC expansion in Asia and Latin America. Free cash flow is not expected to turn positive until late 2008.
• Key Risks:
  • Asbestos Litigation: The Company is defending against approximately 19,388 asbestos-related claims (plus 9,189 against a subsidiary). While the Company has ~$130 million in confirmed insurance coverage and does not anticipate a material adverse effect, litigation outcomes are uncertain.
  • Competition: Intense price competition in the European PMC market continues to pressure margins.
  • Currency: Significant exposure to foreign exchange rates, particularly the Euro, impacts reported sales and income.
  • Raw Materials: Sensitivity to petroleum prices, which affect the cost of polymer monofilaments.

Investor Verification Checklist

• European PMC Recovery: Verify if the Company successfully regained volume and pricing power in Europe in 2007 as projected.
• Capital Expenditure Execution: Monitor the progress and cost of the $150 million strategic investment program in Asia and Latin America.
• Asbestos Liability: Track the number of new claims filed and the status of insurance coverage disputes.
• Free Cash Flow: Assess whether the high capital spending and pension contributions delay the return to positive free cash flow beyond late 2008.
• Convertible Notes: Monitor the stock price relative to the $44.52 conversion price of the 2026 convertible notes to assess potential dilution.